AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

INSPIRATION HEALTHCARE GROUP PLC

Remuneration Information Nov 8, 2018

7711_dirs_2018-11-08_f50f43d8-4490-4f62-bc73-d7c340477f47.html

Remuneration Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6885G

Inspiration Healthcare Group PLC

08 November 2018

8 November 2018

Inspiration Healthcare Group plc

("Inspiration Healthcare" or the "Company")

Grant of Options

Inspiration Healthcare Group plc (AIM: IHC), the global medical device company, announces that, on 7th November 2018 the Company granted enterprise management incentive options ("EMI Options") over 348,603 new ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") to certain persons discharging managerial responsibilities ("PDMRs") and employees under the Inspiration Healthcare Group plc Long Term Incentive Plan ("Option Scheme"). Following this grant, the Company has granted options over a total of 608,941 new Ordinary Shares representing approximately 2% of the Company's existing issued ordinary share capital.

The EMI Options are exercisable at nil cost and are subject to a performance condition, to be measured over a three-year period ending on 31 January 2021, of growth in earnings per Ordinary Share in issue ("EPS") of 40% or more compounded over the three-year period.  If the growth in EPS is less than 40% but greater than 35% the number of EMI Options available for exercise will be capped at 75% of those granted.  If the growth in EPS is less than 35% but greater than 30% the number of EMI Options available for exercise will be capped at 50% of those granted.  If the growth in EPS is less than 30% the EMI Options will lapse.

If they vest and subject to the rules of the Option Scheme, the EMI Options are exercisable for a period of two years following publication of the audited accounts of the Company for the financial year ending on 31 January 2021.

The Company announces the following PDMR dealings in accordance with article 19(3) of the Market Abuse Regulation:

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Neil Campbell

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Inspiration Healthcare Group plc

b)

LEI

213800GKFT3ENAPMDL15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10p each

ISIN: GB00BXDZL105

b)

Nature of the transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s) Volume(s)
Nil cost 65,385

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

7th November 2018

f)

Place of the transaction

Outside of a trading venue

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mike Briant

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Inspiration Healthcare Group plc

b)

LEI

213800GKFT3ENAPMDL15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10p each

ISIN: GB00BXDZL105

b)

Nature of the transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s) Volume(s)
Nil cost 86,014

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

7th November 2018

f)

Place of the transaction

Outside of a trading venue

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Toby Foster

2

Reason for the notification

a)

Position/status

Group Sales Director

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Inspiration Healthcare Group plc

b)

LEI

213800GKFT3ENAPMDL15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10p each

ISIN: GB00BXDZL105 

b)

Nature of the transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s) Volume(s)
Nil cost 57,692

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

7th November 2018

f)

Place of the transaction

Outside of a trading venue

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name 

Simon Travers

2

Reason for the notification

a)

Position/status

Head of Regulatory Affairs and Quality Assurance

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name 

Inspiration Healthcare Group plc

b)

LEI

213800GKFT3ENAPMDL15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10p each

ISIN: GB00BXDZL105 

b)

Nature of the transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s) Volume(s)
Nil cost 23,252

d)

Aggregated information-

Aggregated volume

- Price 

N/A - single transaction

e)

Date of the transaction

7th November 2018

f)

Place of the transaction

Outside of a trading venue

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jon Ballard

2

Reason for the notification

a)

Position/status 

Group Financial Controller

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Inspiration Healthcare Group plc

b)

LEI

213800GKFT3ENAPMDL15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10p each

ISIN: GB00BXDZL105

b)

Nature of the transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s) Volume(s)
Nil cost 23,252

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

7th November 2018

f)

Place of the transaction

Outside of a trading venue

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name 

John Nash

2

Reason for the notification

a)

Position/status

Head of Marketing

b)

Initial notification /Amendment

Initial

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Inspiration Healthcare Group plc

b)

LEI

213800GKFT3ENAPMDL15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10p each

ISIN: GB00BXDZL105

b)

Nature of the transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s) Volume(s)
Nil cost 23,252

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

7th November 2018

f)

Place of the transaction

Outside of a trading venue

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Wei Yu

Reason for the notification

a)

Position/status

Head of R&D

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Inspiration Healthcare Group plc

b)

LEI

213800GKFT3ENAPMDL15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10p each

ISIN: GB00BXDZL105

b)

Nature of the transaction

Grant of Options

c)

Price(s) and volume(s)

Price(s) Volume(s)
Nil cost 23,252

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

7th November 2018

f)

Place of the transaction

Outside of a trading venue

Enquiries:

Inspiration Healthcare Group plc

Neil Campbell, Chief Executive Officer

Mike Briant, Chief Financial Officer
Tel: 01455 840555
Nominated Adviser & Broker

Cenkos Securities plc

Mark Connelly (NOMAD)
Tel: 0207 397 8900
Cadogan PR                        

Alex Walters
Tel: 07771 713608

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHQDLFBVFFXFBD

Talk to a Data Expert

Have a question? We'll get back to you promptly.